The agreement with Harvard gives Cynata access to cell-modification technology … – The Australian
The Australian |
The agreement with Harvard gives Cynata access to cell-modification technology …
The Australian The agreement gives the company access to cell-modification technology developed under the direction of Khalid Shah. Cynata said Dr Shah's research team was studying whether modified stem cells could facilitate delivery of purified cancer-killing … Delivering the Triple Whammy that Makes Stem Cell Therapies Commercially … Cynata to Investigate Cell Therapy for Cancer in Major New Collaboration |
